Retraction: CXCL6 promotes renal interstitial fibrosis in diabetic nephropathy by activating JAK/STAT3 signaling pathway
2024
Retraction of CXCL6 Study on Diabetic Nephropathy
Editorial
Author Information
Author(s): Frontiers Editorial Office
Conclusion
The original study's data and conclusions were deemed unreliable due to image integrity concerns.
Supporting Evidence
- Concerns were raised regarding the integrity of the images in the published figures.
- Image duplication concerns were identified in Figure 6C.
- The authors failed to provide a satisfactory explanation during the investigation.
Takeaway
A study about a kidney disease was taken back because some pictures used in it were not trustworthy.
Limitations
Concerns about image integrity were not satisfactorily explained by the authors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website